Federal contract award
HT001422P0039
NUCLEAR MEDICINE IMAGING PRODUCTS FOR MYOCARDIAL INFARCT IMAGING, DIAGNOSTIC IMAGING OF GALL BLADDER DISORDERS, AND BREAST CANCER NODULE IMAGING MEDICINE.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $967.3K |
| Current contract value | $967.3K |
| Potential contract value / ceiling | $967.3K |
| Start date | Mar 10, 2022 |
| Current end date | Mar 10, 2027 |
| Potential end date | Mar 10, 2027 |
| Latest award activity | Mar 17, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 17, 2026 | P00006 | $185.5K | NUCLEAR MEDICINE IMAGING PRODUCTS FOR MYOCARDIAL INFARCT IMAGING, DIAGNOSTIC IMAGING OF GALL BLADDER DISORDERS, AND BREAST CANCER NODULE IMAGING MEDICINE. |
| Mar 11, 2026 | P00005 | $0 | NUCLEAR MEDICINE IMAGING PRODUCTS FOR MYOCARDIAL INFARCT IMAGING, DIAGNOSTIC IMAGING OF GALL BLADDER DISORDERS, AND BREAST CANCER NODULE IMAGING MEDICINE. |
| Mar 4, 2025 | P00004 | $185.8K | NUCLEAR MEDICINE IMAGING PRODUCTS FOR MYOCARDIAL INFARCT IMAGING, DIAGNOSTIC IMAGING OF GALL BLADDER DISORDERS, AND BREAST CANCER NODULE IMAGING MEDICINE. |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
65/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 65/100. Available recorded signals: 60 points.
- Contract end 2027-03-10 (136 days from calculation)
- +35 points
- 23 historical awards in this buyer and category group
- +15 points
- 3 recorded award transactions
- +5 points
- Latest award action: 2026-03-17
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.